Role of the ovary in the adrenal androgen excess of hyperandrogenic women

Ricardo Azziz, Roger S. Rittmaster, Leisl M. Fox, Edwin L. Bradley, H. Downing Potter, Larry R. Boots

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: To test the hypothesis that ovarian hormones in women with hyperandrogenism alter adrenocortical steroidogenesis. Design: Combination of two prospective studies. Setting: Academic medical centers. Patient(s): Eighteen hyperandrogenic patients demonstrating hirsutism with either hyperandrogenemia, oligomenorrhea, or both. Eighteen healthy nonhirsute eumenorrheic untreated women served as controls. Interventions: Blood sampling basally and after acute adrenal stimulation with ACTH, before and after 20-24 weeks of leuprolide administration. Nine patients also received 0.625 mg/d of oral conjugated esterified estrogens and 10 mg of medroxyprogesterone acetate days 1-12 of the month (i.e., estrogen replacement therapy [ERT]), whereas the remaining nine did not. Main Outcome Measure(s): Before and after the administration of the GnRH agonist (GnRH- a), the basal concentrations of DHEAS; and the levels of androstenedione (A4), DHEA, androstenediol, 11β-hydroxyandrostenedione (11-OHA4), and cortisol before and 60 minutes after acute adrenal stimulation, were measured. Result(s): Levels of DHEAS, androstenediol, and 11-OHA4 decreased by 15%30%, regardless of whether patients initially had or did not have DHEAS excess. However, only hyperandrogenic patients with elevated levels of DHEAS showed a significant decrease in basal DHEA levels. No statistically significant difference in the response of either androgen to ACTH (1-24) stimulation was noted with ovarian suppression, regardless of initial DHEAS level or use of ERT. Conclusion(s): We found no evidence that ovarian hormone secretion affected adrenal steroidogenesis, and those women with the highest adrenal androgen levels had the least response to GnRH-a suppression. These findings further support the concept of an intrinsic, and possibly primary, abnormality of adrenocortical steroidogenesis in a subset of hyperandrogenic women that is independent of ovarian abnormalities.

Original languageEnglish (US)
Pages (from-to)851-859
Number of pages9
JournalFertility and sterility
Volume69
Issue number5
DOIs
StatePublished - Jan 1 1998

Fingerprint

Androgens
Ovary
Androstenediol
Estrogen Replacement Therapy
Dehydroepiandrosterone
Gonadotropin-Releasing Hormone
Oligomenorrhea
Hormones
Leuprolide
Cosyntropin
Hyperandrogenism
Conjugated (USP) Estrogens
Hirsutism
Medroxyprogesterone Acetate
Androstenedione
Adrenocorticotropic Hormone
Hydrocortisone
Outcome Assessment (Health Care)
Prospective Studies

Keywords

  • Adrenal
  • Androgens
  • Gonadotropin- releasing hormone analogues
  • Hirsutism
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Azziz, R., Rittmaster, R. S., Fox, L. M., Bradley, E. L., Potter, H. D., & Boots, L. R. (1998). Role of the ovary in the adrenal androgen excess of hyperandrogenic women. Fertility and sterility, 69(5), 851-859. https://doi.org/10.1016/S0015-0282(98)00033-8

Role of the ovary in the adrenal androgen excess of hyperandrogenic women. / Azziz, Ricardo; Rittmaster, Roger S.; Fox, Leisl M.; Bradley, Edwin L.; Potter, H. Downing; Boots, Larry R.

In: Fertility and sterility, Vol. 69, No. 5, 01.01.1998, p. 851-859.

Research output: Contribution to journalArticle

Azziz, R, Rittmaster, RS, Fox, LM, Bradley, EL, Potter, HD & Boots, LR 1998, 'Role of the ovary in the adrenal androgen excess of hyperandrogenic women', Fertility and sterility, vol. 69, no. 5, pp. 851-859. https://doi.org/10.1016/S0015-0282(98)00033-8
Azziz R, Rittmaster RS, Fox LM, Bradley EL, Potter HD, Boots LR. Role of the ovary in the adrenal androgen excess of hyperandrogenic women. Fertility and sterility. 1998 Jan 1;69(5):851-859. https://doi.org/10.1016/S0015-0282(98)00033-8
Azziz, Ricardo ; Rittmaster, Roger S. ; Fox, Leisl M. ; Bradley, Edwin L. ; Potter, H. Downing ; Boots, Larry R. / Role of the ovary in the adrenal androgen excess of hyperandrogenic women. In: Fertility and sterility. 1998 ; Vol. 69, No. 5. pp. 851-859.
@article{9b208fe5ef6c4dfc911c8aa9f534d5d9,
title = "Role of the ovary in the adrenal androgen excess of hyperandrogenic women",
abstract = "Objective: To test the hypothesis that ovarian hormones in women with hyperandrogenism alter adrenocortical steroidogenesis. Design: Combination of two prospective studies. Setting: Academic medical centers. Patient(s): Eighteen hyperandrogenic patients demonstrating hirsutism with either hyperandrogenemia, oligomenorrhea, or both. Eighteen healthy nonhirsute eumenorrheic untreated women served as controls. Interventions: Blood sampling basally and after acute adrenal stimulation with ACTH, before and after 20-24 weeks of leuprolide administration. Nine patients also received 0.625 mg/d of oral conjugated esterified estrogens and 10 mg of medroxyprogesterone acetate days 1-12 of the month (i.e., estrogen replacement therapy [ERT]), whereas the remaining nine did not. Main Outcome Measure(s): Before and after the administration of the GnRH agonist (GnRH- a), the basal concentrations of DHEAS; and the levels of androstenedione (A4), DHEA, androstenediol, 11β-hydroxyandrostenedione (11-OHA4), and cortisol before and 60 minutes after acute adrenal stimulation, were measured. Result(s): Levels of DHEAS, androstenediol, and 11-OHA4 decreased by 15{\%}30{\%}, regardless of whether patients initially had or did not have DHEAS excess. However, only hyperandrogenic patients with elevated levels of DHEAS showed a significant decrease in basal DHEA levels. No statistically significant difference in the response of either androgen to ACTH (1-24) stimulation was noted with ovarian suppression, regardless of initial DHEAS level or use of ERT. Conclusion(s): We found no evidence that ovarian hormone secretion affected adrenal steroidogenesis, and those women with the highest adrenal androgen levels had the least response to GnRH-a suppression. These findings further support the concept of an intrinsic, and possibly primary, abnormality of adrenocortical steroidogenesis in a subset of hyperandrogenic women that is independent of ovarian abnormalities.",
keywords = "Adrenal, Androgens, Gonadotropin- releasing hormone analogues, Hirsutism, Polycystic ovary syndrome",
author = "Ricardo Azziz and Rittmaster, {Roger S.} and Fox, {Leisl M.} and Bradley, {Edwin L.} and Potter, {H. Downing} and Boots, {Larry R.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0015-0282(98)00033-8",
language = "English (US)",
volume = "69",
pages = "851--859",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Role of the ovary in the adrenal androgen excess of hyperandrogenic women

AU - Azziz, Ricardo

AU - Rittmaster, Roger S.

AU - Fox, Leisl M.

AU - Bradley, Edwin L.

AU - Potter, H. Downing

AU - Boots, Larry R.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Objective: To test the hypothesis that ovarian hormones in women with hyperandrogenism alter adrenocortical steroidogenesis. Design: Combination of two prospective studies. Setting: Academic medical centers. Patient(s): Eighteen hyperandrogenic patients demonstrating hirsutism with either hyperandrogenemia, oligomenorrhea, or both. Eighteen healthy nonhirsute eumenorrheic untreated women served as controls. Interventions: Blood sampling basally and after acute adrenal stimulation with ACTH, before and after 20-24 weeks of leuprolide administration. Nine patients also received 0.625 mg/d of oral conjugated esterified estrogens and 10 mg of medroxyprogesterone acetate days 1-12 of the month (i.e., estrogen replacement therapy [ERT]), whereas the remaining nine did not. Main Outcome Measure(s): Before and after the administration of the GnRH agonist (GnRH- a), the basal concentrations of DHEAS; and the levels of androstenedione (A4), DHEA, androstenediol, 11β-hydroxyandrostenedione (11-OHA4), and cortisol before and 60 minutes after acute adrenal stimulation, were measured. Result(s): Levels of DHEAS, androstenediol, and 11-OHA4 decreased by 15%30%, regardless of whether patients initially had or did not have DHEAS excess. However, only hyperandrogenic patients with elevated levels of DHEAS showed a significant decrease in basal DHEA levels. No statistically significant difference in the response of either androgen to ACTH (1-24) stimulation was noted with ovarian suppression, regardless of initial DHEAS level or use of ERT. Conclusion(s): We found no evidence that ovarian hormone secretion affected adrenal steroidogenesis, and those women with the highest adrenal androgen levels had the least response to GnRH-a suppression. These findings further support the concept of an intrinsic, and possibly primary, abnormality of adrenocortical steroidogenesis in a subset of hyperandrogenic women that is independent of ovarian abnormalities.

AB - Objective: To test the hypothesis that ovarian hormones in women with hyperandrogenism alter adrenocortical steroidogenesis. Design: Combination of two prospective studies. Setting: Academic medical centers. Patient(s): Eighteen hyperandrogenic patients demonstrating hirsutism with either hyperandrogenemia, oligomenorrhea, or both. Eighteen healthy nonhirsute eumenorrheic untreated women served as controls. Interventions: Blood sampling basally and after acute adrenal stimulation with ACTH, before and after 20-24 weeks of leuprolide administration. Nine patients also received 0.625 mg/d of oral conjugated esterified estrogens and 10 mg of medroxyprogesterone acetate days 1-12 of the month (i.e., estrogen replacement therapy [ERT]), whereas the remaining nine did not. Main Outcome Measure(s): Before and after the administration of the GnRH agonist (GnRH- a), the basal concentrations of DHEAS; and the levels of androstenedione (A4), DHEA, androstenediol, 11β-hydroxyandrostenedione (11-OHA4), and cortisol before and 60 minutes after acute adrenal stimulation, were measured. Result(s): Levels of DHEAS, androstenediol, and 11-OHA4 decreased by 15%30%, regardless of whether patients initially had or did not have DHEAS excess. However, only hyperandrogenic patients with elevated levels of DHEAS showed a significant decrease in basal DHEA levels. No statistically significant difference in the response of either androgen to ACTH (1-24) stimulation was noted with ovarian suppression, regardless of initial DHEAS level or use of ERT. Conclusion(s): We found no evidence that ovarian hormone secretion affected adrenal steroidogenesis, and those women with the highest adrenal androgen levels had the least response to GnRH-a suppression. These findings further support the concept of an intrinsic, and possibly primary, abnormality of adrenocortical steroidogenesis in a subset of hyperandrogenic women that is independent of ovarian abnormalities.

KW - Adrenal

KW - Androgens

KW - Gonadotropin- releasing hormone analogues

KW - Hirsutism

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032080183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032080183&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(98)00033-8

DO - 10.1016/S0015-0282(98)00033-8

M3 - Article

C2 - 9591492

AN - SCOPUS:0032080183

VL - 69

SP - 851

EP - 859

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -